Evolus Stock (NASDAQ:EOLS)
Previous Close
$7.19
52W Range
$5.71 - $17.82
50D Avg
$8.11
200D Avg
$10.77
Market Cap
$465.09M
Avg Vol (3M)
$1.33M
Beta
1.07
Div Yield
-
EOLS Company Profile
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.